Skip to main content

4 Result(s)

within O. Boulat Remove this filter

and

  1. No Access

    Article

    A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma

    The potential benefit of rituximab as adjuvant to high-dose therapy (HDT) has been investigated in patients under 60 years with poor-risk (age-adjusted international prognostic index at 2–3) CD20+ diffuse larg...

    D Coso, C Sebban, O Boulat, P Biron, J Rey, T Aurran… in Bone Marrow Transplantation (2006)

  2. No Access

    Article

    Increased NO production in lysinuric protein intolerance

    Lysinuric protein intolerance (LPI) is a disorder of dibasic amino acid transport secondary to mutation of the SLC7A7 gene characterized by renal failure, pulmonary alveolar proteinosis, lupus-like autoimmune sym...

    L. Mannucci, F. Emma, M. Markert, C. Bachmann… in Journal of Inherited Metabolic Disease (2005)

  3. No Access

    Article

    3-Hydroxyisobutyric aciduria with a mild clinical course

    O. Boulat, N. Benador, E. Girardin, C. Bachmann in Journal of Inherited Metabolic Disease (1995)

  4. No Access

    Article

    Pitfalls in aminoacid and organic acid analysis: 3-Hydroxypropionic aciduria

    Pitfalls in organic acid analysis can originate from inadequate methodology, analytical interferences, in vivo interactions and from pre-analytical conditions which often are unknown to the specialized analyti...

    C. Bachmann, O. Boulat, B. J. Meyrat, J. P. Colombo… in European Journal of Pediatrics (1994)